Table 2.

Changes in Glycemic and Lipid Parameters with the Use Of Three Statins

Level	Pitavastatin	Atorvastatin	Pravastatin
Random glucose (mg/dL)*
Baseline	155 ± 53	147 ± 51	136 ± 31
End of study	154 ± 51	176 ± 69†	134 ± 32
HbA1c (%)*
Baseline	7.3 ± 1.0	7.0 ± 1.1	6.9 ± 0.9
End of study	7.2 ± 1.0	7.4 ± 1.2†	6.9 ± 1.0
TC (mg/dL)*
Baseline	225 ± 47	254 ± 40	226 ± 36
End of study	198 ± 34‡	200 ± 52‡	202 ± 34‡
LDL-C (mg/dL)*
Baseline	137 ± 36	155 ± 33	143 ± 31
End of study	113 ± 28	111 ± 27‡	120 ± 27‡
HDL-C (mg/dL)*
Baseline	55 ± 14	55 ± 11	56 ± 12
End of study	56 ± 15	56 ± 18	58 ± 31

HbA_1c = glycosylated hemoglobin; HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-density lipoprotein-cholesterol; TC = total cholesterol.

^*Unless otherwise specified, all P values are not significant.

^†P < 0.001.

^‡P < 0.0001.

Adapted from Yamakawa T, et al. J Atheroscler Thromb 2008;15:269–327.¹²